Surrozen, Inc. (SRZN) Financials

SRZN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 115.6 million 334.3 million
March 31, 2026 120.7 million 398.9 million
Dec. 31, 2025 98.7 million 286.5 million
Sept. 30, 2025 94.0 million 117.6 million

SRZN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -7.4 million 2.9 million
March 31, 2026 -12.6 million 2.1 million
Dec. 31, 2025 -5.9 million 1.0 million
Sept. 30, 2025 -9.1 million 1.0 million

SRZN Net Income

No data available :(

SRZN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 102.0 million - 6.3 million
March 31, 2026 106.9 million 4.9 million 1.9 million
Dec. 31, 2025 89.2 million 5.3 million 1.3 million
Sept. 30, 2025 81.3 million - 7.1 million

SRZN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 23.1 million
March 31, 2026 10.9 million
Dec. 31, 2025 9.1 million
Sept. 30, 2025 8.6 million

SRZN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 19000 8.5 million 6.9 million -
March 31, 2026 120000 9.3 million 6.1 million -
Dec. 31, 2025 59000 9.0 million 4.2 million -
Sept. 30, 2025 24000 7.8 million 4.1 million -

SRZN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 5.0 million -
March 31, 2026 5.0 million 65000
Dec. 31, 2025 528000 45000
Sept. 30, 2025 983000 -

SRZN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SRZN

Price: $23.44

52 week price:
11.39
37.83

Earnings Per Share: -38.60 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 41336

Market Capitalization: 219.2 million

Links: